2). The side effect profiles of rituximab and obinutuzumab were similar, although the number of patients experiencing side effects, including reactions during
Among the patients who received obinutuzumab, the most common adverse side effects compared with chlorambucil alone.11,16 For patients with CLL
Although obinutuzumab improved PFS, it did not improve OS, and, as noted by editorialists, it is unclear whether a component of the improved obinutuzumab response rates relate to the higher doses of obinutuzumab versus rituximab. Nevertheless, these data support obinutuzumab plus chemotherapy as an option for front-line therapy in FL.
However, patients receiving obinutuzumab experienced more serious side effects than those receiving rituximab. The standard first-line
Compare Obinutuzumab vs Rituximab head-to-head with other drugs for uses, ratings, cost, side effects and interactions.
Obinutuzumab was more effective than rituximab but the group receiving obinutuzumab had a different profile of side effects. Importantly, the improvement in
Rovin says side effects of the obinutuzumab regimen were similar to those of standard treatments, with adverse events occurring in 25% and
Gazyva (obinutuzumab) is a cancer medication used to treat chronic lymphocytic leukemia. Includes Gazyva side effects, interactions and indications.
Obinutuzumab should be administered as above. Infusion-related side effects such as rashes, allergic and anaphylactic reactions or cytokine release syndrome.
Comments
one of my own pet peeves, sorry
The story was awesome...
Given all the side effects of mostly untested medications I could honestly see this happening to someone since most new meds get pulled within 5 years because of the side effects.